Last reviewed · How we verify

NCT05242510: DESDEE

Evaluation of Exotropia After Patching the Eye or After Prism Adaptation

Terminated NA Last updated 4 April 2025
What this trial tests

NA trial testing Patching in Exotropia in 1 participant. Terminated before completion.

Timeline
27 August 2024
Primary endpoint
18 September 2024
18 September 2024

Quick facts

Lead sponsorUniversity of Rochester
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment1
Start date27 August 2024
Primary completion18 September 2024
Estimated completion18 September 2024
Sites9 locations across Italy, Israel, Canada, United States, India

Drugs / interventions tested

Conditions studied

Sponsor

University of Rochester

Who can join

Under 17, any sex, with Exotropia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study intends to determine the number and percent of subjects initially diagnosed with divergence excess exotropia which would be reclassified as simulated divergence excess exotropia if tested after 24 hours of monocular occlusion (patching) or after prism adaptation for the distance angle.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Patching

Trials testing the same drug.

Other recruiting trials for Exotropia

Currently open trials in the same condition.

Other University of Rochester trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05242510.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing